Protara Therapeutics (TARA)

• Market cap: $214M
• 1 day: -3.3%
• 5 days: -3.79%
• 1 month: -17.17%
• 3 months: -29.7%
• 6 months: -29.7%
• Year to date: -29.18%
• 1 year: 20.19%
• 5 years: -64.56%
• 10 years: -98.22%
• Sector: Healthcare
• Industry: Biotechnology

About: Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

Employees: 51